Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 12

1.

Wasting and stunting are still prevalent in children with sickle cell anaemia in Lagos, Nigeria.

Esezobor CI, Akintan P, Akinsulie A, Temiye E, Adeyemo T.

Ital J Pediatr. 2016 May 4;42(1):45. doi: 10.1186/s13052-016-0257-4.

2.

Effects of nutritional intake on disease severity in children with sickle cell disease.

Mandese V, Marotti F, Bedetti L, Bigi E, Palazzi G, Iughetti L.

Nutr J. 2016 Apr 30;15(1):46. doi: 10.1186/s12937-016-0159-8.

3.

Hydroxyurea and growth in young children with sickle cell disease.

Rana S, Houston PE, Wang WC, Iyer RV, Goldsmith J, Casella JF, Reed CK, Rogers ZR, Waclawiw MA, Thompson B; BABY HUG Investigators.

Pediatrics. 2014 Sep;134(3):465-72. doi: 10.1542/peds.2014-0917. Erratum in: Pediatrics. 2015 Sep;136(3):584.

4.

An official American Thoracic Society clinical practice guideline: diagnosis, risk stratification, and management of pulmonary hypertension of sickle cell disease.

Klings ES, Machado RF, Barst RJ, Morris CR, Mubarak KK, Gordeuk VR, Kato GJ, Ataga KI, Gibbs JS, Castro O, Rosenzweig EB, Sood N, Hsu L, Wilson KC, Telen MJ, Decastro LM, Krishnamurti L, Steinberg MH, Badesch DB, Gladwin MT; American Thoracic Society Ad Hoc Committee on Pulmonary Hypertension of Sickle Cell Disease.

Am J Respir Crit Care Med. 2014 Mar 15;189(6):727-40. doi: 10.1164/rccm.201401-0065ST.

5.

Blood transfusion for preventing primary and secondary stroke in people with sickle cell disease.

Wang WC, Dwan K.

Cochrane Database Syst Rev. 2013 Nov 14;(11):CD003146. doi: 10.1002/14651858.CD003146.pub2. Review. Update in: Cochrane Database Syst Rev. 2017 Jan 17;1:CD003146.

6.

Deferasirox: appraisal of safety and efficacy in long-term therapy.

Chaudhary P, Pullarkat V.

J Blood Med. 2013 Aug 5;4:101-10. doi: 10.2147/JBM.S35478. eCollection 2013.

7.

Developmental function in toddlers with sickle cell anemia.

Armstrong FD, Elkin TD, Brown RC, Glass P, Rana S, Casella JF, Kalpatthi RV, Pavlakis S, Mi Z, Wang WC; Baby Hug Investigators.

Pediatrics. 2013 Feb;131(2):e406-14. doi: 10.1542/peds.2012-0283. Epub 2013 Jan 6.

8.

Integrating interactive web-based technology to assess adherence and clinical outcomes in pediatric sickle cell disease.

Crosby LE, Barach I, McGrady ME, Kalinyak KA, Eastin AR, Mitchell MJ.

Anemia. 2012;2012:492428. doi: 10.1155/2012/492428. Epub 2012 Jun 4.

9.

Long-term safety and efficacy of deferasirox (Exjade) for up to 5 years in transfusional iron-overloaded patients with sickle cell disease.

Vichinsky E, Bernaudin F, Forni GL, Gardner R, Hassell K, Heeney MM, Inusa B, Kutlar A, Lane P, Mathias L, Porter J, Tebbi C, Wilson F, Griffel L, Deng W, Giannone V, Coates T.

Br J Haematol. 2011 Aug;154(3):387-97. doi: 10.1111/j.1365-2141.2011.08720.x. Epub 2011 May 19.

10.

Erythrocytapheresis: Do Not Forget a Useful Therapy!

Ullrich H, Fischer R, Grosse R, Kordes U, Schubert C, Altstadt B, Andreu G.

Transfus Med Hemother. 2008;35(1):24-30. Epub 2008 Jan 15.

11.

The use of partial exchange blood transfusion and anaesthesia in the management of sickle cell disease in a perioperative setting: two case reports.

Jaeckel R, Thieme M, Czeslick E, Sablotzki A.

J Med Case Rep. 2010 Mar 5;4:82. doi: 10.1186/1752-1947-4-82.

12.

Growth patterns in children with sickle cell anemia during puberty.

Rhodes M, Akohoue SA, Shankar SM, Fleming I, Qi An A, Yu C, Acra S, Buchowski MS.

Pediatr Blood Cancer. 2009 Oct;53(4):635-41. doi: 10.1002/pbc.22137.

Supplemental Content

Support Center